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. The present consideration concerns a group of 29 aliphatic secondary alcohols, ketones and related esters evaluated by JECFA at the 59th and 69th meetings in 2002 and 2008 . This revision is made due to the inclusion of nine additional substances cleared for genotoxicity concern in FGE.205 Revision 1. The substances were evaluated through a stepwise approach that integrates information on structure-activity relationships, intake from current uses, toxicological threshold of concern and available data on metabolism and toxicity. The Panel agrees with the application of the Procedure as performed by JECFA for all 29 substances considered in this FGE. For all substances, the Panel concludes that there is 'no safety concern at the estimated levels of intake as flavouring substances based on the MSDI approach'. For all 29 substances, the specifications for the materials of commerce have also been considered and found adequate. Ten out of the 14 substances for which use levels became available exceed the modified theoretical added maximum daily intake (mTAMDI) and more reliable exposure data are required to finalise their evaluation. On the basis of such data, additional toxicological data might become necessary. For 15 substances, use levels are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more refined exposure assessment to finalise the evaluation.
Summary
Following a request from the European Commission, the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific opinion to provide scientific advice to the Commission on the implications for human health of chemically defined flavouring substances used in or on foodstuffs in the Member States. In particular, the Panel was requested to consider the Joint FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000.
1 These flavouring substances are listed in the Union List, which was adopted by Commission Regulation (EU) No 872/2012 2 and its consecutive amendments.
The Flavouring Group Evaluation 63 Revision 3 (FGE.63Rev3) deals with the consideration of 29 aliphatic secondary alcohols, ketones and related esters evaluated by JECFA at its 59th and 69th meetings (JECFA, 2003 (JECFA, , 2009b . Sixteen of the 29 substances 02.099, 02.104, 02.136, 02.155, 02.252, 07.081, 07.099, 07.101, 07.102, 07.190, 07.247, 07.256, 09.281, 09.282 and 09.936] possess an a,b-unsaturated structure which is considered a structural alert for genotoxicity. Therefore, the 16 substances have been evaluated by the European Food Safety Authority (EFSA) in FGE.204, FGE.206, FGE.205 and FGE.205Rev1 , respectively, and the genotoxicity concern could be ruled out.
The Panel concluded that the 29 substances in the JECFA flavouring group of aliphatic secondary alcohols, ketones and related esters are structurally related to the group of 49 saturated and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or branched-chain carboxylic acids evaluated in FGE.07Rev4.
The Panel agrees with the application of the Procedure as performed by JECFA for the 29 substances considered in this FGE.
For the 29 substances, the JECFA evaluation was based on maximised survey-derived daily intake (MSDI) values derived from production figures from the European Union (EU). For all 29 substances, the Panel agreed with the JECFA conclusion that, according to the Procedure, they are not expected to be of safety concern when used as flavouring substances based on the MSDI approach.
In order to determine whether the conclusion for the 29 JECFA-evaluated substances can be applied to the materials of commerce, it is necessary to consider the available specifications. Adequate specifications including complete purity criteria and identity became available for all the JECFAsubstances evaluated in this FGE.
Thus, for 29 JECFA-evaluated aliphatic secondary alcohols, ketones and related esters 02.099, 02.104, 02.136, 02.155, 02.252, 07.015, 07.069, 07.081, 07.099, 07.100, 07.101, 07.102, 07.114, 07.123, 07.151, 07.190, 07.240, 07.247, 07.249, 07.256, 09.281, 09.282, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] , the Panel agrees with the JECFA conclusion: 'No safety concern at current levels of intake when used as flavouring agents, based on the MSDI approach'.
For 14 substances 02.099, 02.104, 02.136, 02.155, 02.252, 07.081, 07.099, 07.101, 07.102, 07.190, 09.281, 09.282 and 09.936] , industry has submitted use levels for normal and maximum use. Based on these normal use levels, modified theoretical added maximum daily intake (mTAMDI) values can be calculated. Four flavouring substances 07.099, 07.101 and 09.936] have mTAMDI intake estimates below the threshold of concern for their structural class. The Panel noted that these four substances are evaluated via the A-side of the Procedure. For 10 substances 02.099, 02.104, 02.136, 02.155, 07.081, 07.102, 07.190, 09.281 and 09.282] , the mTAMDI values are above the thresholds of concern for their structural class II of 540 lg/person per day. Therefore, for these 10 substances, more reliable exposure data are required in order to finalise the evaluation. On the basis of such additional data, these flavouring substances should be reconsidered using the Procedure. Following this procedure, additional toxicological data might become necessary. For the remaining 15 substances evaluated through the Procedure, use levels are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more refined exposure assessment in order to finalise the evaluation. The Panel concluded that for the two representative substances: oct-1-en-3-one .081] and pent-1-en-3-one ], the positive effects in the bacterial mutagenicity assays cannot be overruled by one negative and one equivocal gene mutation test in mammalian cells. Accordingly, an in vivo Comet assay on the first site of contact (e.g. the stomach or duodenum) and on the liver was requested for the most potent substance, pent-1-en-3-one . As an alternative, a transgenic animal assay would also be acceptable.
On 10 March 2015, the applicant submitted additional studies on the representative substances and ]. These studies are intended to cover the substances in this group, namely: FL-nos: 02. 023, 02.099, 02.104, 02.131, 02.136, 02.155, 02.187, 07.161, 07.210, 09 .281 and 09.282.
Terms of Reference
The European Commission requests the European Food Safety Authority (EFSA) to evaluate this new information and, depending on the outcome, proceed to the full evaluation on the above mentioned flavouring substances in accordance with Commission Regulation (EC) No 1565/2000 1 .
Interpretation of the Terms of Reference
The European Commission requests EFSA to carry out a safety assessment on the substances oct-1-en-3-ol, pent-1-en-3-ol, hex-1-en-3-ol, dec-1-en-3-ol, 1-hepten-3-ol, oct-1-en-3-one, pent-1-en-3-one, oct-1-en-3-yl acetate and oct-1-en-3-yl butyrate 02.099, 02.104, 02.136, 02.155, 07.081, 07.102, 09.281 and 09.282 
Data and methodologies
The approach used by EFSA for safety evaluation of flavouring substances is referred to in Commission Regulation (EC) No 1565/2000 1 , hereafter named the 'EFSA Procedure'. This Procedure is based on the opinion of the Scientific Committee on Food (SCF, 1999), which has been derived from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA, 1995 (JECFA, , 1996 (JECFA, , 1997 (JECFA, , 1999 , hereafter named the 'JECFA Procedure'. The CEF Panel compares the JECFA evaluation of structurally related substances with the result of a corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring substances are of no safety concern at their estimated levels of intake, whether additional data are required or whether certain substances should not be put through the EFSA Procedure.
The following issues are of special importance.
Intake
In its evaluation, the Panel as a default uses the 'maximised survey-derived daily intake' (MSDI) approach to estimate the per capita intakes of the flavouring substances in Europe.
In its evaluation, JECFA includes intake estimates based on the MSDI approach derived from both European and USA production figures. The highest of the two MSDI figures is used in the evaluation by JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, meaning that certain flavouring substances have been evaluated by JECFA only on the basis of these figures. For Register substances for which this is the case, the Panel will need the European Union (EU) production figures in order to finalise the evaluation.
When the Panel examined the information provided by the European Flavour Industry on the use levels in various foods, it appeared obvious that the MSDI approach in a number of cases would grossly underestimate the intake by regular consumers of products flavoured at the use level reported by industry, especially in those cases where the annual production values were reported to be small. In consequence, the Panel had reservations about the data on use and use levels provided and the intake estimates obtained by the MSDI approach. It is noted that JECFA, at its 65th meeting considered 'how to improve the identification and assessment of flavouring agents, for which the MSDI estimates may be substantially lower than the dietary exposures that would be estimated from the anticipated average use levels in foods' (JECFA, 2006) .
In the absence of more accurate information that would enable the Panel to make a more realistic estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate of the daily intakes per person using a modified 'theoretical added maximum daily intake' (mTAMDI) approach based on the normal use levels reported by industry.
As information on use levels for the flavouring substances has not been requested by JECFA or has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the mTAMDI approach for the substances evaluated by JECFA. The Panel will need information on use levels in order to finalise the evaluation.
Threshold of 1.5 lg/person per day (Step B5) used by JECFA JECFA uses the threshold of concern of 1.5 lg/person per day as part of the evaluation procedure: The Committee noted that this value was based on a risk analysis of known carcinogens which involved several conservative assumptions. The use of this value was supported by additional information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the Committee, flavouring substances for which insufficient data are available for them to be evaluated using earlier steps in the Procedure, but for which the intake would not exceed 1.5 lg/person per day would not be expected to present a safety concern. The Committee recommended that the Procedure for the Safety Evaluation of Flavouring Agents used at the 46th meeting be amended to include the last step on the right-hand side of the original Procedure ('Do the condition of use result in an intake greater than 1.5 lg per day?') (JECFA, 1999) .
In line with the opinion expressed by the Scientific Committee on Food (SCF, 1999) , the Panel does not make use of this threshold of 1.5 lg/person per day.
Genotoxicity
As reflected in the opinion of SCF (1999), the Panel has in its evaluation focussed on a possible genotoxic potential of the flavouring substances or of structurally related substances. Generally, substances for which the Panel has concluded that there is an indication of genotoxic potential in vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through the Procedure.
Specifications
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of JECFA, since the Panel requests information on, e.g. isomerism.
Structural Relationship In the consideration of the JECFA-evaluated substances, the Panel will examine the structural relationship and metabolism features of the substances within the flavouring group and compare this with the corresponding Flavouring Group Evaluation (FGE).
2.1.
History of the evaluation of the substances in the present FGE At its 59th meeting, JECFA evaluated a group of 39 flavouring substances consisting of aliphatic secondary alcohols, ketones and related esters (JECFA, 2003) . One of the JECFA-evaluated substances is not in the Register [(E,R)-3,7-dimethyl-1,5,7-octatrien-3-ol (JECFA No: 1154) ], and 25 substances 02.099, 02.102, 02.104, 02.136, 02.193, 07.044, 07.048, 07.081, 07.082, 07.099, 07.101, 07.102, 07.104, 07.105, 07.106, 07.107, 07.121, 07.138, 07.139, 07.177, 07.188, 07.244, 07.247 and 07.256 ] are a,b-unsaturated ketones or precursors for such, which have been considered together with other a,b-unsaturated substances. FGE.63 therefore only dealt with 13 JECFA-evaluated substances.
The first revision of FGE.63, FGE.63Rev1, included the consideration of six additional substances 07.099, 07.190, 07.247, 07.256 and 09.936] evaluated by JECFA at their 59th and 69th meetings. Furthermore, for six substances 07.114, 09.657, 09.658, 09.923 and 09.925] industry, European Flavour and Fragrance Association (EFFA), had submitted information on the stereoisomeric composition, and for three substances, 07.100 and 09.658] , provided the EU production volumes (EFFA, 2010) .
The second revision of FGE.63, FGE.63Rev2, included the consideration of one additional substance, 4-methylpent-3-en-2-one ]. This substance is an a,b-unsaturated ketone and was originally evaluated in FGE.204 (EFSA CEF Panel, 2012a) in which it was considered not to be of concern with respect to genotoxicity. The present revision of FGE.63, FGE.63Rev3, includes the consideration of six additional substances from the 59th meeting of JECFA, 02.099, 02.104, 02.136, 07.081 and 07.102, ] and three substances 09.281 and 09.282 ] from the 69th meeting of JECFA. These substances are a,b-unsaturated secondary alcohols and ketones and were originally evaluated in FGE.205 (EFSA CEF Panel, 2012c) and FGE.205Rev1 (EFSA CEF Panel, 2016) in which they were considered to be of no concern with respect to genotoxicity. Therefore, these nine substances can be evaluated in the present FGE using the Procedure. Additional specifications, use levels and tonnage data have also become available for these substances and considered by the Panel (EFFA, 2016 Of the 39 aliphatic secondary alcohols, ketones and related esters evaluated by JECFA at the 59th meeting (JECFA, 2003) , one of which is not in the Register ((E,R)-3,7-dimethyl-1,5,7-octatrien-3-ol (JECFA No: 1154) ) and one is no longer supported by industry (2-pentylbut-1-en-3-one (DG SANCO, 2012) . Thirteen substances (all saturated aliphatic secondary alcohols, ketones and related esters) were included in the first release of FGE.63. The remaining 25 substances are a,b-unsaturated ketones or precursors for such, which have been considered together with other a,b-unsaturated substances with respect to a possible genotoxic potential. Ten of these 25 substances were evaluated by EFSA for their genotoxic potential: three [FL-no: 07.099, 07.247 and 07.256] in FGE.206 (EFSA CEF Panel, 2011), one (4-methylpent-3-en-2-one [FL-no: 07 .101]) in FGE.204 (EFSA CEF Panel, 2012a) and six [FL-no: 02.023, 02.099, 02.104, 02.136, 07.081 and 07.102] in FGE.205Rev1 (EFSA CEF Panel, 2016) . For the remaining 14 substances 02.139, 07.044, 07.048, 07.082, 07.104, 07.105, 07.106, 07.107, 07.121, 07.139, 07.177, 07.188 07.097, 09.938, 07.239, 09.565 and 09.822] have been considered in various other FGEs. Therefore, FGE.63Rev3 will address 6 substances that were evaluated by JECFA at their 69th meeting.
EFSA considerations
For sixteen a,b-unsaturated ketones evaluated by JECFA at its 59th and 69th meetings (JECFA, 2003 (JECFA, , 2009b , EFSA concluded that these were not of concern with respect to genotoxicity. Six substances evaluated in FGE.206 and one substance evaluated in FGE.204 were included in FGE.63Rev1 and FGE.63Rev2, respectively; nine substances evaluated in FGE.205Rev1 will be included in the current revision of FGE.63Rev3. These, together with 13 aliphatic secondary alcohols, ketones and related esters already considered in FGE.63, will thus comprise 29 flavouring substances.
The Panel concluded that these 29 substances are structurally related to the group of 49 saturated and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or branched-chain carboxylic acids evaluated by EFSA in Flavouring Group Evaluation 07, Revision 4 (FGE.07Rev4) (EFSA CEF Panel, 2012b).
Isomers

JECFA status
Fifteen substances in the group of JECFA-evaluated aliphatic secondary alcohols, ketones and related esters have a chiral centre 02.099, 02.104, 02.136, 02.155, 02.252, 07.069, 09.281, 09.282, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] and eight substances can exist as geometrical isomers 07.099, 07.114, 07.123, 07.190, 07.247, 07.256 and 09.936] .
EFSA considerations
Flavouring substance ] is a mixture of four geometrical isomers; however, no quantitative information on the occurrence of these isomers is provided. The Panel considered the available information on ] adequate. For ], the CASrn specifies that it consists of the E-isomer. The 13 chiral substances considered in this FGE are reported as racemates (see Table 1 ). 
For all substances, industry has submitted production figures for the EU. For 14 substances 02.099, 02.104, 02.136, 02.155, 02.252, 07.081, 07.099, 07.101, 07.102, 07.190, 09.281, 09.282 and 09.936] , industry has submitted normal and maximum use levels (Flavour Industry, 2004; EFFA, 2016 ) (see Table C .1). Based on the normal use levels, mTAMDI values can be calculated (see Table C .2), (EFSA, 2004) . For 10 substances 02.099, 02.104, 02.136, 02.155, 07.081, 07.102, 07.190 3.2. Genotoxicity 3.2.1. Genotoxicity studies -text taken 4 from the 59th JECFA meeting and the 69th JECFA meeting (JECFA, 2003 (JECFA, , 2009b Genotoxicity data were only available from the 59th meeting and only in vitro studies were performed.
In vitro
Assays for reverse mutation were performed with 6-methylhept-5-en-2-one .015] and 6-methyl-3,5-heptadien-2-one [FL-no: 07.099]. There was no evidence of mutagenicity for 6-methylhept-5-en-2-one at concentrations up to 380 lg/plate in TA98, TA100, TA1535 or TA1537 strains of Salmonella Typhimurium (Florin et al., 1980) . There was also no evidence of mutagenicity for 6-methyl-3,5-heptadien-2-one at concentrations up to 370 lg/plate in the same strains (Florin et al., 1980) . For a summary of in vitro genotoxicity data considered by JECFA, see . The effect, measured only at high concentrations, approaching cytotoxic levels, can be considered to be a threshold effect, not mediated by direct interaction with DNA. In addition, induction of aneuploidy described in the paper is strongly potentiated by ice treatments included in the experimental protocol, consistently with tubulin dissociation at low temperature in vitro; in the absence of this passage the effect is very weak. Therefore, the effect could be considered as an effect occurring only under unrealistic experimental conditions and the extrapolation of this result to the in vivo situation in humans is questionable. Furthermore, it is well recognised that the relevance of fungal systems is limited when induction of aneuploidy in mammalian systems has to be evaluated.
Pseudo-ionone ] was considered with respect to genotoxicity in FGE.206 (EFSA CEF Panel, 2011) where the Panel concluded that the data available ruled out the concern for genotoxicity. Pseudo-ionone was tested in S. Typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 in the presence or absence of S9 and it is concluded that under the test conditions applied pseudo-ionone is not mutagenic in bacteria. Pseudo-ionone was also evaluated in an in vitro micronucleus assay in human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and absence of rat S9 fraction as an in vitro metabolising system. Under the conditions of this study, pseudo-ionone was not clastogenic and/or aneugenic in cultured human lymphocytes.
In vitro genotoxicity data are also available for 10 supporting substances.
No evidence of mutagenicity obtained with bacterial and/or mammalian cells systems was reported for: one saturated aliphatic acyclic secondary alcohol Beside the negative results in in vitro bacterial point mutation tests, acetone .050] showed no evidence of increased sister chromatid exchanges in several cytogenetic assays on different mammalian cells, as well as no induction of chromosomal aberrations in Chinese hamster ovary cells up to very high concentrations. Only one test on hamster lung fibroblasts (conducted at an unspecified acetone concentration) and an aneuploidy induction test on Saccharomyces cerevisiae (about 7% acetone) gave positive results. However, these two studies were considered not relevant on the basis of their poor quality and taking into account all the other negative genotoxicity results obtained with acetone, including results in vivo (see below).
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was considered with respect to genotoxicity in FGE.206 (EFSA CEF Panel, 2011) where the Panel concluded that the data available ruled out the concern for genotoxicity. 6-Methylhepta-3,5-dien-2-one was tested in S. Typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 in the presence or absence of S9 and it was concluded that under the test conditions applied 6-methylhepta-3,5-dien-2-one is not mutagenic in bacteria. 6-Methylhepta-3, 5-dien-2-one was also evaluated in an in vitro micronucleus assay in human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and absence of rat S9 fraction as an in vitro metabolising system. Under the conditions of this study, 6-methylhepta-3, 5-dien-2-one was not clastogenic and/aneugenic in cultured human lymphocytes.
In vivo data are available for four supporting substances: one saturated aliphatic secondary alcohol .079] and three saturated aliphatic ketones 07.050 and 07.053] , which exhibited no genotoxic potential in the micronucleus cytogenetic assay at doses approaching the LD 20 and the LD 50 of the tested substances.
Conclusion on genotoxicity
On the basis of available data from in vitro and in vivo tests on candidate and supporting substances, it can be concluded that the 49 candidate substances included in this group exhibit no genotoxic potential.
For a summary of in vitro/in vivo genotoxicity data considered by EFSA, see Tables A.2 (EFSA CEF Panel, 2011) . In this revision of FGE.63, the data below are of importance for the assessment of the genotoxic potential of six candidate substances 07.099, 07.190, 07.247, 07.256 and 09.936] , which have a structural alert for genotoxicity.
In vitro
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was tested in S. Typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 in the presence or absence of S9. In the first experiment, the concentrations tested were 1.6, 8, 40, 200, 1,000 and 5,000 lg/plate, and the plate incorporation methodology was used. Severe toxicity was observed at 5,000 lg/plate in all strains (complete killing of bacteria). No increase in revertant colonies was observed at any of the tested concentrations. In the second experiment, the concentrations were 20.5, 51.2, 128, 320, 800, 2,000 and 5,000 lg/plate of 6-methylhepta-3,5-dien-2-one, and treatments in the presence of S9 were carried out according to the pre-incubation method. In the absence of S9, the standard plate incorporation method was performed. Slight thinning of the bacterial lawn or complete killing of the bacteria was observed in all strains at 2,000 and 5,000 lg/plate in the absence of S9. In the presence of S9, cytotoxicity was observed at 800 lg/plate and above and severe toxicity (complete killing of bacteria) was observed at 5,000 lg/plate in all strains (Williams, 2009a) . The study design complied with current recommendations (OECD 471; GLP) and an acceptable top concentration was achieved. There was no evidence of mutagenic effect induced by 6-methylhepta-3,5-dien-2-one in any of the strains, either in the absence or presence of S9. No precipitation was observed at any tested concentrations (Williams, 2009a) . It is concluded that under the test conditions applied, 6-methylhepta-3,5-dien-2-one [FL-no: 07.099] is not mutagenic in bacteria.
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was evaluated in an in vitro micronucleus assay in human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and absence of rat S9 fraction as an in vitro metabolising system. The assay was performed in accordance with the OECD 487 Guideline and in compliance with Good Laboratory Practice (GLP). In a preliminary toxicity study, a wide range of concentrations up to 2,000 lg/mL of 6-methylhepta-3,5-dien-2-one was tested. The highest concentration used in the main test (450 lg/mL) was limited by toxicity observed in the preliminary study. Cells were stimulated for 48 h with phytohaemaglutinin to produce exponentially growing cells, and then treated for 3 h (followed by 21 h recovery) with 0, 225, 325 or 450 lg/mL of 6-methylhepta-3,5-dien-2-one in the absence of S9 and 0, 225, 300 and 350 lg/mL in the presence of S9, respectively. The levels of toxicity (reduction in replication index) at the top concentrations were 60% and 51% without and with S9, respectively. In a parallel assay, cells were treated for 24 h with 0, 100, 120 or 150 lg/mL of 6-methylhepta-3,5-dien-2-one in the absence of S9 with no recovery period. The top concentration induced 56% toxicity. There were two replicate cultures per treatment, and 1,000 binucleate cells per replicate (i.e. 2,000 cells per dose) were scored for micronuclei. No evidence of chromosomal damage or aneuploidy was observed by increased levels of micronucleated binucleate cells (MNBN) in the presence or absence of S9 metabolic activation (Whitwell, 2010) . Under the conditions of this study, 6-methylhepta-3,5-dien-2-one was not clastogenic and/aneugenic in cultured human lymphocytes.
Conclusion on genotoxicity
The Panel concluded that the in vitro genotoxicity data on 6-methylhepta-3,5-dien-2-one [FL-no: 07.099] do not indicate genotoxic potential.
As 6-methylhepta-3,5-dien-2-one ] is a representative with respect to genotoxicity for the following substances 07.190, 07.247, 07.256 and 09.936] , the genotoxicity concern for these five substances can be ruled out and all six substances can be evaluated using the Procedure.
For a summary of in vitro genotoxicity data considered by EFSA in FGE.206, see Table A .4. 4-Methylpent-3-en-2-one [FL-no: 07.101] is considered negative in the Ames test with S. Typhimurium tester strains consistent with the requirements for current regulatory guidelines. Statistically significant increase in the number of revertant colonies observed in tester strain TA1535 in the absence of S9-mix metabolism in one experiment following treatment with 4-methylpent-3-en-2-one are judged not biologically relevant, since they were not reproduced in the second experiment (Williams, 2009b; Ballantyne, 2011b ).
Genotoxicity studies -text taken
Investigations at chromosome and genome levels in mammalian cells in vitro showed that 4-methylpent-3-en-2-one induced a small but statistically significant increase in the frequency of MNBN only in the presence of S9-mix metabolism following a 3-h treatment at the highest concentration tested (981.4 lg/mL). However, only one replicate culture fell outside the historical vehicle control range values. Following additional scoring of 2,000 erythrocytes, the resulting MNBN frequencies, although still significantly higher than concurrent vehicle control, lied within historical control range values. In a second confirmatory experiment (3-h treatment in the presence of S9-mix) performed at concentrations lower than concentrations used in the previous experiment, due to an unexplained shift of toxicity (comparable toxicity to those observed in the first experiment, but at lower concentrations), no significant increase in MNBN frequencies was observed. Based on these results the Panel concluded that 4-methylpent-3-en-2-one did not induce micronuclei in human peripheral blood lymphocytes, both in the absence and presence of rat liver S9-mix metabolism (Stone, 2011).
Conclusion on genotoxicity
The Panel noted that for 4-methylpent-3-en-2-one [FL-no: 07.101], the data available showed that it did not induce mutations in bacteria or micronuclei in human peripheral blood lymphocytes, neither in the presence nor in the absence of rat liver S9-mix metabolic activation. Based on these findings, the Panel concluded that 4-methylpent-3-en-2-one does not present a safety concern with respect to genotoxicity and accordingly the flavouring substance can be evaluated using the Procedure.
For a summary of in vitro genotoxicity data considered by EFSA in FGE.204, see Table A .5. Pent-1-en-3-one [FL-no: 07.102] tested in vivo in a combined micronucleus and comet assay did not show genotoxic effects in either the liver or duodenum of treated rats. The negative results of the bone marrow micronucleus assay are considered inconclusive because there is no evidence of bone marrow exposure to the tested substance. However, as results of the in vitro micronucleus assay were negative, no additional in vivo follow-up studies on clastogenicity and aneugenicity were needed. The bacterial mutation assay provided for oct-1-en-3-one .081] confirms the weak mutagenic effect in bacteria shown in previous studies, but does not clarify the mechanism of action. The liver comet assay is considered of limited validity due to low values of mean tail intensity and tail moment. However, based on the data available on the most potent of the two representative substances for subgroup 1.2.2, pent-1-en-3-one .102], the Panel concluded that there is no concern for genotoxicity and accordingly nine substances in subgroup 1. 
Genotoxicity studies -text taken
EFSA considerations on genotoxicity for substances in FGE.63Rev3
The Panel concluded that the data available do not preclude evaluation of the 29 aliphatic secondary alcohols, ketones and related esters through the Procedure.
3.3.
Application of the Procedure for the safety evaluation to 29 aliphatic secondary alcohols, ketones and related esters by JECFA (2003, 2009b) JECFA concluded all 29 aliphatic secondary alcohols, ketones and related esters at step A3 in the JECFA Procedure, i.e. the substances are expected to be metabolised to innocuous products (step 2) and the intakes for all substances are below the thresholds for their structural classes I and II (step A3).
In conclusion, JECFA evaluated all 29 substances as to be of no safety concern at current levels of intake used as flavouring agents based on the MSDI approach.
The evaluations of the 29 aliphatic secondary alcohols, ketones and related esters are summarised in Table B Forty-eight substances were concluded at step A3 using the EFSA Procedure, i.e. the substances are expected to be metabolised to innocuous products (step 2) and the estimated daily intakes for these 48 substances are below the thresholds of concern for their structural classes, based on the MSDI approach (step A3).
One candidate substance, 5-methylheptan-3-one , cannot be predicted to be metabolised to innocuous products and therefore proceeds to step B3. The estimated daily intake of this substance of 0.32 lg/capita per day does not exceed the threshold of concern for structural class II (540 lg/person per day). Accordingly, the candidate substance proceeds to step B4 of the Procedure. On the basis of a study on the neurotoxic effects of orally administered 5-methylheptan-3-one ] to male rats, a no observed adverse effect level (NOAEL) of 82 mg/kg body weight (bw) per day was established (International Business Machines Corporation (IBM Corp.), 1989) . This NOAEL provides a margin of safety of 1.5 9 10 7 based on the estimated intake of the candidate substance of 0.32 lg/capita per day. Based on results of the safety evaluation sequence, this candidate substance does not pose a safety concern when used as flavouring substance at the estimated level of intake, based on the MSDI approach.
The stepwise evaluations of the 49 substances are summarised in Table B. 2.
EFSA considerations
Two substances were allocated to structural class I by JECFA, whereas EFSA allocated these into structural class II.
Otherwise, the Panel agrees with the application of the Procedure as performed by JECFA for the 29 substances in the group of aliphatic secondary alcohols, ketones and related esters, and concluded similar to JECFA that 29 flavouring substances are not of safety concern when used as flavouring substances, based on the MSDI approach.
Conclusions
The FGE.63Rev3 deals with the consideration of 29 aliphatic secondary alcohols, ketones and related esters evaluated by JECFA at its 59th and 69th meetings (JECFA, 2003 (JECFA, , 2009b . Sixteen of the 29 substances 02.099, 02.104, 02.136, 02.155, 02.252, 07.081, 07.099, 07.101, 07.102, 07.190, 07.247, 07.256, 09.281, 09.282 and 09.936] possess an a,b-unsaturated structure which is considered a structural alert for genotoxicity. Therefore, the 16 substances have been evaluated by EFSA in FGE.204, FGE.206 and FGE.205Rev1 , respectively, and the genotoxicity concern could be ruled out.
For all 29 substances, the Panel agreed with the JECFA conclusion that, according to the Procedure, they are not expected to be of safety concern when used as flavouring substances based on the MSDI approach.
In order to determine whether the conclusion for the 29 JECFA-evaluated substances can be applied to the materials of commerce, it is necessary to consider the available specifications. Adequate specifications including complete purity criteria and identity are available for all the JECFA substances evaluated in this FGE.
Thus, for the 29 JECFA-evaluated aliphatic secondary alcohols, ketones and related esters 02.099, 02.104, 02.136, 02.155, 02.252, 07.015, 07.069, 07.081, 07.099, 07.100, 07.101, 07.102, 07.114, 07.123, 07.151, 07.190, 07.240, 07.247, 07.249, 07.256, 09.281, 09.282, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] , the Panel agrees with the JECFA conclusionˋNo safety concern at estimated levels of intake as flavouring substances, based on the MSDI approach 0 . For 14 substances 02.099, 02.104, 02.136, 02.155, 02.252, 07.081, 07.099, 07.101, 07.102, 07.190, 09.281, 09.282 and 09.936] , industry has submitted use levels for normal and maximum use. Based on these normal use levels, mTAMDI values can be calculated. Four flavouring substances 07.099, 07.101 and 09.936] have mTAMDI intake estimates below the threshold of concern for their structural class. The Panel noted that these four substances are evaluated via the A-side of the Procedure. For 10 substances 02.099, 02.104, 02.136, 02.155, 07.081, 07.102, 07.190, 09.281 and 09.282] , the mTAMDI values are above the thresholds of concern for their structural class II of 540 lg/person per day. Therefore, for these 10 substances more reliable exposure data are required in order to finalise the evaluation. On the basis of such additional data, these flavouring substances should be reconsidered using the Procedure. Following this procedure, additional toxicological data might become necessary. For the remaining 15 substances evaluated through the Procedure, use levels are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more refined exposure assessment in order to finalise the evaluation. S. Typhimurium TA98, TA100, TA1535, TA1537,
Documentation provided to EFSA
Escherichia coli
WP2uvrA 5-5,000
lg/plate Negative (a) Shimizu et al. (1985) h Ames test (b) S. Typhimurium TA97, TA98, TA100, TA102, TA104, TA1535, TA1537
Up to 10 mg/plate Kapp et al. (1993) Brooks et al. (1988) Chemical Name [FL-no] Pentan-3-one 
